InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Nucleic Acid Therapeutics Market – (By Technology (RNA targeted therapeutics, Gene Therapies, Epigenetic and microRNA modulating therapies, Genome editing therapies, Others), By Application (Autoimmune Disorders, Genetic Disorders, Infectious Diseases, Cancer, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034.”
According to the latest research by InsightAce Analytic, the Global Nucleic Acid Therapeutics CDMO Market Size is valued at USD 2,540.9 Million in 2024 and is predicted to reach USD 8,688.2 Million by the year 2034 at an 13.2% CAGR during the forecast period for 2025-2034.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1348
Nucleic acid therapeutics encompasses a range of medical treatments that utilize therapeutic nucleic acids, such as DNA and RNA, to treat or prevent various diseases. The global market for these therapies is expected to witness significant growth, primarily driven by a rising prevalence of chronic illnesses and genetic disorders, which has intensified research initiatives aimed at strengthening healthcare systems worldwide. Additionally, the increasing demand for pharmaceutical products and healthcare services—alongside continuous innovation in biologics and gene-based therapies—continues to accelerate market expansion.
Nonetheless, several challenges may impede this growth trajectory, including high development and treatment costs, limited availability of skilled professionals, and the reliance on outdated technological infrastructure in certain regions. Despite these constraints, the market is experiencing positive momentum owing to the rising adoption of personalized medicine approaches, where treatments are tailored to individual genetic profiles.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1348
List of Prominent Players in the Nucleic Acid Therapeutics Market:
- Novartis
- Moderna Inc
- BioNTech
- Arrowhead Pharmaceuticals
- Merck
- Thermo Fischer Scientific
- Sanofi
- Alnylam Pharmaceuticals
- Sarepta Therapeutics
- Qiagen
- Imugene
- Copernicus Therapeutics Inc.
- Protagonist Therapeutics
- Arbutus Biopharma
- Agilent Technologies
- Silence Therapeutics (UK),
- Astellas Pharma Inc. (Japan),
- CureVac SE (Germany),
- Sirnaomics (US),
- Arcturus Therapeutics Inc. (US)
- Other Market Players
Market Dynamics:
Drivers-
The growth of the nucleic acid therapeutics market is primarily fueled by the increasing prevalence of genetic disorders that are often difficult to treat, such as cystic fibrosis, muscular dystrophy, and various forms of cancer. Accelerated development in this field is being driven by significant investments in research and development from pharmaceutical companies, government bodies, and academic institutions. Additionally, supportive government initiatives aimed at promoting drug development have streamlined regulatory approval processes and created a favorable environment for market expansion.
Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1348
Challenges:
Despite its promising outlook, the nucleic acid therapeutics market faces several challenges. Chief among them are the high costs associated with development and manufacturing, which limit patient access and hinder widespread adoption. Furthermore, the technological complexity of these therapies presents significant barriers to entry, and the stringent regulatory requirements contribute to prolonged approval timelines.
Regional Trends:
North America is projected to hold a leading share in the nucleic acid therapeutics market, driven by the high prevalence of chronic diseases such as diabetes and cancer, growing demand for precision medicine, and favorable government policies that support innovation. Europe also commands a significant portion of the market, supported by robust funding for research and development, advancements in gene therapy, and a rising incidence of genetic conditions.
Recent Developments:
- In April 2024, Arrowhead Pharmaceuticals, Inc. announced the dosing of its investigational RNA interference (RNAi) therapeutic, ARO-CFB, in a Phase 1/2a clinical trial. The trial included up to sixty-six healthy volunteers and patients with complement-mediated kidney disease.
- In Aug 2022, Merck and Orna Therapeutics entered into a collaboration agreement to jointly explore, create, and market various initiatives, such as vaccines and treatments, in the fields of infectious disease and oncology.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1348
Segmentation of Nucleic Acid Therapeutics Market-
By Technology-
- RNA Targeted Therapeutics
- Gene Therapies
- Epigenetic and microRNA Modulating Therapies
- Genome Editing Therapies
- Others
By Application-
- Autoimmune Disorders
- Genetic Disorders
- Infectious Diseases
- Cancer
- Others
By End-User-
- Hospitals & Clinics
- Academic & Research Institutes
- Others
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Get more information: @
https://www.insightaceanalytic.com/report/global-nucleic-acid-therapeutics-cdmo-market/1348
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
